Rapid Selection and Proliferation of CD133(+) Cells from Cancer Cell Lines: Chemotherapeutic Implications

Cancer stem cells (CSCs) are considered a subset of the bulk tumor responsible for initiating and maintaining the disease. Several surface cellular markers have been recently used to identify CSCs. Among those is CD133, which is expressed by hematopoietic progenitor cells as well as embryonic stem c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelly, Sarah E., Di Benedetto, Altomare, Greco, Adelaide, Howard, Candace M., Sollars, Vincent E., Primerano, Donald A., Valluri, Jagan V., Claudio, Pier Paolo
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2851647/
https://www.ncbi.nlm.nih.gov/pubmed/20386701
http://dx.doi.org/10.1371/journal.pone.0010035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2851647/
https://www.ncbi.nlm.nih.gov/pubmed/20386701
http://dx.doi.org/10.1371/journal.pone.0010035

Ejemplares similares